Interventional Cardiologists near Hasbrouck Heights, NJ

Care Philosophy: Dr. Anuj Shah is a Cardiologist, Vein Specialist and Internist with offices stretched across in multiple locations in NJ-Nutley, Passaic, Jersey City, Newark, Irvington, and Paterson. At Apex, we believe in saving limbs means saving lives. S

Biography: Tamim Nazif, MD is the Director of Clinical Research for Columbia Interventional Cardiovascular Care,Director of the Interventional Cardiology Fellowship Program, and an associate professor in medicine at Columbia University Irving Medical Center. Dr. Nazif specializes in interventional cardiology and the treatment of heart valve disease. Dr. Nazif attended Columbia University College of Physicians and Surgeons, did his residency at University of California, San Francisco Department of Medicine, San Francisco, CA, and his fellowship in interventional cardiology and Structural Heart Disease at Columbia University Irving Medical Center.

Biography: Dr. Yumiko Kanei, MD is an Internist who practices in New York, NY. She is 52 years old and has been practicing for 27 years. Dr. Yumiko Kanei, MD is affiliated with Mount Sinai Morningside.

Biography: Dr. Prakash Krishnan, MD is a Cardiology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 28 years. Dr. Prakash Krishnan, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Margaret McEntegart, MD, holds esteemed positions at Columbia, where she serves as the Director of Complex PCI and CTO programs, overseeing one of New York City's leading programs for complex coronary care at Columbia University Irving Medical Center. Additionally, she holds the role of Director of Cardiac Catheterization Laboratories at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, further demonstrating her expertise and leadership in the field.Internationally recognized as both a clinician and researcher, Dr. McEntegart brings a wealth of experience to her current roles. Prior to joining Columbia, she served as a consultant interventional cardiologist at Golden Jubilee National Hospital, where she played a pivotal role in establishing and leading the CTO and Complex PCI Program. During her tenure, she also led the MitraClip service and contributed to the development of the transcatheter aortic valve replacement (TAVR) service.Dr. McEntegart's impact extends beyond her clinical work. She has been instrumental as a principal investigator in various local, national, and international clinical trials. Additionally, she has co-supervised interventional cardiology Ph.D. research fellows alongside Professor Colin Berry, fostering the growth of knowledge in the field. Notably, she established the Glasgow Coronary Core Lab, which played a crucial role in research analyses for significant trials such as the UK multicenter T-TIME trial and the BCIS-REVIVED study.Within Columbia, Dr. McEntegart is actively involved in training and supporting junior faculty, providing supervision and mentorship to interventional cardiology fellows, and promoting education among cardiologists and healthcare professionals.

Biography: Dr. Parasuram Krishnamoorthy, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 39 years old and has been practicing for 16 years. Dr. Parasuram Krishnamoorthy, MD is affiliated with Mount Sinai Queens.

Care Philosophy: The art of medicine is always a collective effort - in order for a physician to provide optimal medical care, he or she must be surrounded and supported by the optimal team. Weill Cornell has afforded me the opportunity to work in such an environment and provide the finest of medical care. Moreover, my dual role as provider and educator allows me to train and mentor the brightest of future physicians.

Biography: Megha Prasad, MD, MS, is an interventional cardiologist and the Director of the Cardiorenal Program at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. She earned her medical degree from the University of Southern California and a Master's in Clinical Research and Translational Science from Mayo Clinic Rochester.Dr. Prasad completed her internal medicine and cardiology training at Mayo Clinic in Rochester, MN, and her interventional cardiology training at Columbia University Irving Medical Center in New York City. She further honed her skills with advanced training in Complex and High-Risk Percutaneous Coronary Interventions and Mechanical Circulatory Support at Columbia.As an Assistant Professor of Medicine, Dr. Prasad focuses on coronary physiology and imaging, particularly in women's cardiovascular health. She sees patients at Columbia University Irving Medical Center in Washington Heights, actively contributing to patient care, research, and education.

Biography: Dr. Reisman received his Medical Degree from Sackler School of Medicine, New York State Program. He did his Internship at Robert Wood Johnson Hospital in New Brunswick. He finished both Residency in Internal Medicine and Cardiology Fellowship at St. Luke's Roosevelt Hospital in New York. Dr. Reisman completed Interventional Cardiology at University of California San Diego Medical Center in San Diego.Dr. Reisman has a very productive career as exemplified by authorship and co-authorship of over 100 publications. He is a highly regarded practitioner in the field of interventional cardiology and a leader in national education forum.Dr. Reisman servesas Director of Structural Heart Disease at Weill Cornell Medicine

Biography: Dr. Parikh is the Director of Endovascular Services at Columbia University Irving Medical Center and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons. His clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and peripheral vascular interventions. He has an active practice in cardiovascular medicine with a focus on atherosclerotic vascular disease and intervention throughout the circulation. This includes coronary artery disease, peripheral arterial disease including claudication and critical limb ischemia, renovascular disease, cerebrovascular disease and venous disease and thrombosis. He is a nationally recognized clinician educator and investigator in vascular medicine and intervention. He has won numerous teaching awards locally and co-directs several national educational programs for physicians in training and for continuing medical education in conjunction with the Cardiovascular Research Foundation (CRF), the American College of Cardiology (ACC) and the Society for Cardiac Angiography and Intervention (SCAI). His research interests focus on novel endovascular devices for the treatment of vascular disease. He has been the site and national principal investigator for several clinical trials and has authored more than 50 original manuscripts and reviews in basic and clinical cardiovascular medicine. He lectures frequently at national meetings including Transcatheter Cardiovascular Therapeutics (TCT), ACC and SCAI amongst others. Dr. Parikh grew up in northern New Jersey and graduated from Livingston High School. He went on to graduate magna cum laude from Harvard College with an AB in Biomedical Sciences and Engineering and went on to earn his MD from the Johns Hopkins University School of Medicine with Phi Beta Kappa and Alpha Omega Alpha honors. He completed his internal medicine residency and chief residency at the Massachusetts General Hospital, cardiovascular medicine and interventional cardiology fellowships at the Brigham and Women's Hospital and vascular medicine and intervention fellowship at the Massachusetts General Hospital, all teaching hospitals affiliated with the Harvard Medical School in Boston. He is board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Vascular Medicine and Endovascular Intervention.

Biography: Dr. William Prabhu is an interventional cardiologist at Columbia. He graduated from SUNY Upstate medical school at Syracuse in 2009. He completed residency and a chief residency at UVM medical center from 2009-2012. He then completed general cardiology, interventional cardiology, structural heart and peripheral vascular fellowships at Brown University from 2013-2018. From 2018-2021 he practiced primarily in Rockland county performing the highest volume of cardiac catheterizations, PCIs, and TAVRs in the county during his time there. In 2022, he joined the faculty at Columbia's Interventional Cardiovascular Care program. Along with his busy clinical responsibilities, Dr. Prabhu participates in multiple randomized controlled trials as part of his academic work with CUIMC.Dr. Prabhu performs cardiac catheterizations, peripheral vascular, and structural heart procedures at Columbia University Irving Medical Center. He is the Associate Director of the cardiac Cath lab at NewYork-Presbyterian Hudson Valley Hospital. Dr. Prabhu takes pride in bringing modern cardiac interventional techniques and advanced treatments for coronary artery disease, structural heart disease, peripheral vascular disease and pulmonary embolism to Westchester County.

Care Philosophy: Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Giora Weisz, MD, is an Associate Professor in Clinical Medicine at Columbia University Irving Medical Center and serves as the Director of the cardiac Cath Lab at NewYork-Presbyterian Hudson Valley Hospital. He graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel, and completed his residency in internal medicine and cardiology fellowship at the Carmel Medical Center in Haifa, Israel. Dr. Weisz finished his interventional cardiology training at Lenox Hill Hospital in New York.As an interventional cardiologist, Dr. Weisz focuses on current and innovative technologies. His expertise includes novel robotic-enhanced coronary interventions, with a special emphasis on navigation and positioning technologies. He also has a keen interest in the management of incomplete revascularization, novel intravascular imaging, and strategies for preventing contrast-induced nephropathy.

Biography: Allan Schwartz, MD is a Cardiologist, Chief, Division of Cardiology, Vice Chair, Department of Medicine and Seymour Milstein and Harold Ames Hatch Professor of Clinical Medicine at Columbia University Medical Center/Columbia University College of Physicians and Surgeons. He graduated magna cum laude in physics and mathematics from the City College of New York in 1967. He received an MA in physics in 1968 from Harvard University and an MD from the College of Physicians and Surgeons in 1974, where he was awarded the Robert Loeb and Janeway Prizes. He completed an internship and residency in internal medicine at the Presbyterian Hospital and he received a fellowship in clinical and research cardiology at Massachusetts General Hospital. Dr. Schwartz returned to the College of Physicians & Surgeons in 1978 as an academic clinical cardiologist. Dr. Schwartz has been vigorously involved in patient care, education of medical students, medical housestaff and cardiology fellows, as well as clinical research with a current focus on valvular heart disease. He has progressively assumed various leadership and administrative roles serving as Director of the Cardiac Catheterization Laboratory and Associate Director of the Division of Cardiology and the Seymour Milstein and Harold Ames Hatch Professor of Clinical Medicine. Dr. Schwartz has also played an important administrative role within the Department of Medicine, serving as Vice Chairman of the Department of Medicine. Dr. Schwartz has been the driving force behind the development of the NewYork-Presbyterian/Columbia University Medical Center Cardiovascular Service Line and the development of the new Vivian and Seymour Milstein Family Heart Center. Under Dr. Schwartz's leadership, there has been a major increase in the breadth of cardiology clinical and research activities, resulting in the Division of Cardiology's attaining international prominence and emerging as one of the leading cardiology training centers in the United States.

Biography: Dr. Frank Iacovone, MD is a Cardiology Specialist who practices in Belleville, NJ. He is 58 years old. Dr. Frank Iacovone, MD is affiliated with Clara Maass Medical Center, Cooperman Barnabas Medical Center and Newark Beth Israel Medical Center.

Biography: Dr. Shmuel Chen is an Assistant Professor of Medicine at Weill Cornell Medicine and the NewYork-Presbyterian Hospital. He specializes in interventional cardiology including the treatment of coronary and structural heart disease.Dr. Chen received his medical degree from The Hebrew University School of Medicine (Jerusalem, Israel) as well as a PhD in Neurobiology from the Hebrew University School of Medicine. He completed his training in internal medicine and cardiology at the Hebrew University, Hadassah Medical Center (Jerusalem, Israel), where he also served as a Staff Cardiologist and a Lecturer in Cardiology. He subsequently moved to New York City and dedicated over 2 years to a prestigious research fellowship at the Cardiovascular Research Foundation (CRF). During this time, he worked towards designing and undertaking cutting-edge clinical trials and research in interventional cardiology. He has lead and extensively contributed to a number of projects and studies, exploring all aspects of cardiovascular and structural heart disease. These works have been published in leading medical journals in the field. After this focused research time, Dr. Chen joined The Columbia University Irving Medical Center and the NewYork-Presbyterian Hospital (New York, NY) for a two-year interventional cardiology fellowship program in July 2019. He gained specialty training in coronary interventions and strcutrual heart disease including aortic, mitral, tricuspid, paravalvular leak, patent foramen ovale (PFO), and left atrial appendage procedures. He joined the Weill Cornell Medical Center in September 2021 for another year of advanced structural heart training and served as an Instructor in Medicine.

Biography: Dr. S. Chiu Wong is a Professor of Medicine of the Greenberg Division of Cardiology in the Department of Medicine of the Weill Medical College of Cornell University. He is the Director of Cardiac Catheterization laboratories at the NewYork-Presbyterian/Weill Cornell Medical Center.Dr. Wong graduated Summa Cum Laude from Columbia College in May 1980 and received his Doctor of Medicine degree from Columbia University, College of Physicians and Surgeons in May 1984. Following his medical internship, residency, and clinical cardiology training at St. Luke's/Roosevelt Medical Center in New York City, he spent one additional stent fellowship year in 1991 under the tutorage of Dr. Richard Schatz at Scripps's Clinic and Research Foundation in La Jolla, California. He is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.After his medical training, Dr. Wong joined the Cardiology Research Foundation at the Washington Hospital in 1992 and was appointed as Director of Coronary Stent Program in 1993. In 1995, Dr. Wong spearheaded a new cardiac catheterization program at the New York Hospital Medical Center of Queens where he assumed the directorship of coronary interventions. In October 1999, Dr. Wong was recruited to the New York Presbyterian Hospital - Cornell Campus as Director of Cardiac Catheterization Laboratories.Dr. Wong has published extensively in the field of interventional cardiology with special focus on new device angioplasty, saphenous vein graft intervention, cardiogenic shock, and drug eluting stent. His current clinical research interests include novel drug eluting stent designs, access site and PFO closure devices, percutaneous valve repair, and application of stem cell technology in the treatment of myocardial ischemia. In the past five years, Dr. Wong and his colleagues had participated in multiple US pivotal trials that led to the FDA approval of both drug eluting stents for the treatment of symptomatic obstructive coronary artery disease. Dr. Wong has recently served as the national principal investigation in the ECLIPSE trial which evaluated the safety and efficacy of an extra-vascular bio-degradable access site closure device in patients undergoing coronary or peripheral diagnostic/interventional procedures compare to the standard treatment of manual compression.Other exciting areas of ongoing research include percutaneous treatment valvular disease states including mitral regurgitation and aortic stenosis, assessment of novel pharmacologic agents to enhance safety of angioplasty procedures.His clinical research activities have been published in Journal of American College of Cardiology, American Journal of Cardiology, American heart Journal and he has presented his findings at numerous national and international meetings including American Heart Association, American College of Cardiology, Transcatheter Therapeutics, Summer in Seattle, Taiwan Society of Cardiology and Asia Pacific Cardiology Congress. He is recruited to serve as member of the Scientific Advisory Board of multiple major US medical device companies.